Skip to content
DefDex

Federal award

SCANDINAVIAN BIOPHARMA HOLDING AB

W81XWH20C0137

Contract

Obligated and Ceiling

Obligated (net)
$40,613,408.05
Ceiling (potential value, not spending)
$51,663,681.78
Current value
$51,663,681.78
Gross positive obligations
$40,613,408.05

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
SCANDINAVIAN BIOPHARMA HOLDING AB · ZKASUJ7ZZC98
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
SCANDINAVIAN BIOPHARMA HOLDING AB · ZKASUJ7ZZC98
Awarding agency
Department of War · sub-agency 97DH · office HT9425
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
Q517
Industry (NAICS)
541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PIID
W81XWH20C0137
Award type code
D
Actions
13 · Sep 25, 2020 to Jun 5, 2026
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History13

Award actions
DateFYModAction typeObligationCompany in company totals
Jun 5, 2026FY2026P00012B$0.00
—
May 4, 2026FY2026P00011C$1,182,300.00
—
Feb 13, 2026FY2026P00010B$0.00
—
Dec 8, 2025FY2026P00009C$433,300.84
—
May 29, 2025FY2025P00008B$46,000.00
—
Mar 10, 2025FY2025P00007B$606,000.00
—
Sep 18, 2024FY2024P00006B$20,479,340.43
—
Aug 29, 2023FY2023P00005B$254,430.00
—
Apr 11, 2023FY2023P00004M$0.00
—
Apr 5, 2023FY2023P00003B$5,186,161.00
—
May 5, 2022FY2022P00002B$4,306,102.00
—
Oct 28, 2020FY2021P00001M$0.00
—
Sep 25, 2020FY20200—$8,119,773.78
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.